Hugh McMillan

Professor, Department of Pediatrics, University of Ottawa

Pediatric Neurologist and Neuromuscular specialist at the Children’s Hospital of Eastern Ontario

Email Hugh

Dr. McMillan is a Pediatric Neurologist with specialization in Clinical Neurophysiology and Neuromuscular medicine at the Children’s Hospital of Eastern Ontario. He is a Professor in the Department of Pediatrics, Faculty of Medicine at the University of Ottawa.  He holds a Clinical Research Chair (Level 2) at the University of Ottawa and is a Clinical Investigator at the CHEO Research Institute

He has been an author of over 125 publications in peer-review journals and was a co-editor of a Pediatric Electromyography textbook.  He is also a leader in clinical and translational research in pediatric neurology & neuromuscular medicine.

Dr. McMillan completed a Neuromuscular and Neurophysiology Fellowship at Boston Children’s Hospital, Harvard University and the Lahey Clinic, Tufts University; a Pediatric Neurology Residency at the Children’s Hospital of Eastern Ontario, University of Ottawa and a Pediatric Residency at McMaster Children’s Hospital, McMaster University.

Dr. Hugh McMillan profile picture.

Read more about Hugh

Academic web profile
ORCiD profile

Recent publications

Sutton, ER, Beauvais, A, Yaworski, R, McMillan, HJ, Kothary, R. Maternal-Fetal Administration of Risdiplam Partially Rescues the SMNΔ7 Mouse Model of Spinal Muscular Atrophy. Ann Neurol. 2026. PMID:42458739

Degan, C, Tobin, RA, de Vries, SI, Jiménez-Requena, A, Peco, A, Guglieri, M et al.. Evaluation of a serum protein signature as monitoring biomarker for Duchenne muscular dystrophy in a long-term clinical trial with corticosteroids. Skelet Muscle. 2026. PMID:42443978

Nasomyont, N, Appel, A, Apkon, S, Hoskin, J, Surampudi, PN, Truba, N et al.. Navigating sexual health, fertility, and adult wellness in individuals with Duchenne muscular dystrophy: Current standards of care and future directions. J Neuromuscul Dis. 2026. 22143602261454423 PMID:42439098

Mah, JK, Lochmüller, H, Ward, L, Selby, K, Gonorazky, H, Sbrocchi, AM et al.. Expanding Vamorolone Treatment Access for Canadians with Duchenne Muscular Dystrophy. Can J Neurol Sci. 2026. 1-4 PMID:42438401

Alazem, H, Friesen, AH, Dennison, T, Nizam, A, Larin, ML, Longmuir, PE et al.. Mobile robotic walker enables precision moderately intense exercise and environmental exploration in a child with cerebral palsy GMFCS IV: assessment of use, user experience and quantitative impact in a home and hospital based setting. Disabil Rehabil Assist Technol. 2026. 1-11 PMID:42423986

Poulin, KL, René, CA, Smith, IC, Vacratsis, PO, Burger, D, McMillan, HJ et al.. Extracellular vesicles as biomarkers of disease progression and therapeutic response in patients with spinal muscular atrophy. Mol Ther Adv. 2026.34 (2)201757 PMID:42232219

McMillan, HJ, Oskoui, M. Predicting Functional Decline in Duchenne Muscular Dystrophy: Advancing Trial Readiness and Patient Counseling. Neurology. 2026.106 (12)e214882 PMID:42190149

Wood, CL, Babalola, F, Benjamin, RW, Lam, C, McAdam, L, Nicolau, S et al.. Optimizing Care for Growth and Puberty in Duchenne Muscular Dystrophy: A Survey of Clinical Practice in the OPTIMIZE DMD Consortium. Muscle Nerve. 2026.74 (2)433-439 PMID:42178495

Guridi, M, De Ford, C, See, CG, Murphy, AP, Chen, Y, Scharke, M et al.. Assessing biomarkers of bone metabolism and the role of the interleukin-6 signaling pathway in patients with Duchenne muscular dystrophy. Neuromuscul Disord. 2026.62 106414 PMID:41894885

Sbrocchi, AM, Kinnett, K, Lautatzis, ME, McMillan, HJ, Selby, KA, Veerapandiyan, A et al.. Adrenal Suppression in Duchenne Muscular Dystrophy: Management Strategies Incorporating Novel Steroid Vamorolone. J Endocr Soc. 2026.10 (2)bvaf181 PMID:41509125

See more on PubMed